Connect with us


14 restaurants added to Michelin Guide Singapore 2021



The Michelin Guide Singapore has celebrated its fifth anniversary with 14 restaurants added to this year’s list, including one promoted to three stars, one to two stars, five to one star, and seven newly awarded one star.

After debuting in the 2019 edition with two Michelin stars, Zén has been promoted to three Michelin stars in 2021, the highest accolade in the Michelin Guide. 

With Zén’s promotion, Singapore is now home to a total of three 3-star restaurants, including Les Amis and Odette, which were elevated to this category in 2019, the Michelin Guide said in a press release early this month.

Meanwhile, Jaan by Kirk Westaway received a second Michelin star in 2021 for its modern reinterpretation of British gastronomy through an innovative culinary lens. 

Michelin inspectors praise the restaurant for embodying the quintessence of fine dining and its smart use of amazing British produce to create a romantic setting that has it all – food, service, ambiance, and spectacular views. 

With this recognition, Jaan by Kirk Westaway joins four other restaurants with two Michelin stars in Singapore, namely Saint Pierre, Shisen Hanten, Shoukouwa, and Waku Ghin.

This year also saw twelve new restaurants receiving one Michelin star in the city-state.

Of these, four are making their debut in the 2021 edition with one Michelin star (Art in the National Gallery, Cloudstreet, Oshino, and Sommer), three have gained one Michelin star for their new openings (Basque Kitchen by Aitor, Lerouy, and Whitegrass), while five have been promoted from Michelin Plate (Cure, Esora, Shang Palace, Thevar, and 28 Wilkie).

With these new additions, Singapore has a total of 41 one-Michelin-star restaurants.

A photo is taken at the ceremony to reveal the Michelin Guide selection 2021 for Singapore. Photo by courtesy of Michelin Guide Singapore

A photo is taken at the ceremony to reveal the Michelin Guide selection 2021 for Singapore. Photo by courtesy of Michelin Guide Singapore

In addition, the Michelin Guide also marks its fifth anniversary in Singapore by launching the first-ever Michelin Guide Young Chef Award, which recognizes a young chef working in a Michelin-starred restaurant “who has exceptional talent and great potential.”

This year’s award went to Cloudstreet’s Chef Mark Tai, a graduate from the Culinary School of America and with more than several years of professional experience both in the hotel and restaurant industries.

“Tai’s expertise and leadership goes beyond the kitchen and shines in its operational and dining aspects, too,” the Michelin Guide Singapore said in its press release.

“Despite the challenges posed by 2020, it has been impressive to observe how the chefs and their teams were able to reinvent and adapt to the unfolding situation,” said Gwendal Poullennec, International Director of the Michelin Guides. 

“On top of managing their restaurants, they also came together in looking out for those who were in need in their communities, from feeding migrant workers and frontline workers, to setting up welfare funds for displaced F&B staff. 

“In this 2021 edition, we pay tribute to the perseverance and dedication of these professionals, who continue to bring us together over the finest gastronomy and experiences. 

“I believe the readers of the Michelin Guide and all food lovers are excited to continue discovering Singapore’s colorful and resilient dining scene, as well as the reinventions that have taken place over the last year and those to come.”



S.Korea urges more testing over fear of holiday COVID-19 surge



South Korean authorities warned people returning from a holiday to get tested even for the mildest COVID-19 type symptoms, especially before clocking in for work amid a new surge in coronavirus cases in and around the capital.

The country, which has been grappling with a fourth wave of infections since early July, will on Friday roll back the allowance gatherings during the Chuseok holiday week to two people after 6 p.m. in the greater Seoul area.

Seoul saw 1,400 daily confirmed cases on average last week, up 11% from a record high of 1,268 the prior week, Vice Health Minister Kang Do-tae said on Wednesday.

Kang urged those returning from the three-day holiday, which started on Monday, to get tested to prevent transmission.

South Korea’s popular tourist island of Jeju saw an average of more than 41,000 visitors a day during the holiday, up from about 32,000 in the same period last year, the Jeju Tourism Association told Reuters. More than 258,000 people have visited the island in six days.

Despite the high daily case numbers, the mortality rate and severe cases have remained relatively low and steady at 0.83% and 312 respectively as of Wednesday, Korea Disease Control and Prevention Agency (KDCA) data showed.

The KDCA reported 1,716 new COVID-19 cases on Wednesday, raising the total to 292,699 infections, with 2,427 deaths.

South Korea struggled to get vaccine supplies initially, but has supercharged its campaign in recent months, administering 71.2% of the 52 million population with at least one dose through Wednesday and fully inoculated 43.2%.


Continue Reading


Japan to double COVID-19 vaccine donations to other countries to 60 mln doses



TOKYO — Japan plans to give other countries 60 million doses of COVID-19 vaccines, Prime Minister Yoshihide Suga said on Thursday, doubling the target from the previous pledge of 30 million doses.

“Today, I am pleased to announce that, with additional contributions, Japan will provide up to approximately 60 million doses of vaccine in total,” Suga said in a pre-recorded video message at the U.S.-hosted Global COVID-19 Summit.

Of the first 30 million, Japan has already provided about 23 million doses mostly to Asian destinations including Taiwan, Vietnam and Indonesia.

Japan initially lagged behind other industrialised nations in its vaccination rollout, but now 55% of its population are fully vaccinated, roughly on a par with the United States.

Earlier this month, in a surprise announcement, Suga said that he was stepping down as prime minister, ending a one-year term that has seen his support crumble as COVID-19 cases surged.


Continue Reading


U.S. FDA clears Pfizer COVID-19 booster for older and at-risk Americans



The U.S. Food and Drug Administration on Wednesday authorized a booster dose of the Pfizer Inc and BioNTech COVID-19 vaccine for those 65 and older, all people at high risk of severe disease, and others who are regularly exposed to the virus.

The decision paves the way for a quick rollout of the booster shots as soon as this week for millions of people who had their second dose of the vaccine at least six months ago.

The change to the vaccine’s emergency use authorization will allow boosters for groups such as health-care workers, teachers and day care staff, grocery workers and those in homeless shelters or prisons, FDA acting Commissioner Janet Woodcock said in a statement.

Pfizer had asked the FDA to expand its vaccine approval to include boosters for all people aged 16 and older and presented data last week to an outside FDA panel of advisers that it said showed waning immunity over time.

The panel voted against the proposition that boosters were needed by everyone but said evidence showed they were helpful to older people and those at high risk. 

Dr. William Schaffner, medical director of the National Foundation for Infectious Diseases (NFID), said the FDA’s statement was more expansive in who it included as eligible for boosters when compared to the panel’s recommendation.

“Very broad indeed, especially that ‘among others.’ That could essentially give the green light for giving boosters to a very substantial proportion of the previously vaccinated adult population,” said Schaffner, who serves as the NFID’s liaison to the Advisory Committee on Immunization Practices (ACIP) at the U.S. Centers for Disease Control and Prevention (CDC).

ACIP could vote Thursday on the use of a third shot of the vaccine, an agency official said at a public meeting of the panel on Wednesday.

“Tomorrow’s ACIP meeting at the CDC will be focused on turning this into an official recommendation for implementation,” said Dr. Amesh Adalja, senior scholar at the Johns Hopkins University Center for Health Security.

The FDA authorization was “generally in line” with the advisory panel vote, said Dr. Jesse Goodman, an infectious disease expert at Georgetown University in Washington and former chief scientist at the FDA.

“These are pretty broad categories that give a fair amount of latitude to the judgment of healthcare providers and people providing immunizations,” he added.

President Joe Biden and eight top health officials including Woodcock announced in August the government’s intention to roll out booster shots for people aged 16 and older this week, pending approval by the FDA and CDC.

But the advisory panel said there was not enough evidence to support booster shots for that population and also sought more safety data. The FDA does not have to follow the advisory panel’s recommendation, but often does.

The agency could revisit the issue for a broader authorization in the future.

“This first FDA authorization of a COVID-19 vaccine booster is a critical milestone in the ongoing fight against this disease,” said Pfizer chief Albert Bourla. The company had argued that boosters are needed for the general population.

Top FDA members have been split on the need for boosters for the general population, with Woodcock backing them while some of the agency’s senior scientists argued that current evidence does not support them.

Some countries, including Israel and Britain, have already rolled out COVID-19 booster campaigns. The United States authorized extra shots for people with compromised immune systems last month and over 2 million people have already received a third shot, CDC data showed.


Continue Reading